ReviewCurrent opinion in nephrology and hypertension2017
Calciphylaxis.
Review in Current opinion in nephrology and hypertension, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed.
- Calciphylaxis complicated by NDM-1-producing Pseudomonas aeruginosa: first experience with cefepime-zidebactam alongside phage therapy in the USA.The Lancet. Infectious diseases · 2026Review
- The Interplay of Cardiovascular Comorbidities and Anticoagulation Therapy in ESRD Patients on Haemodialysis-The South-Eastern Romanian Experience.Biomedicines · 2025Article
- Navigating the patient-provider relationship during severe illness with lessons from a qualitative perspective of calciphylaxis.Scientific reports · 2025Article
- Chronic leg ulcers in a patient with Hyperoxaluria type 1: a rare and challenging diagnosis.Oxford medical case reports · 2025Article
- Calciphylaxis of the Upper Limbs-A Rare and Serious Disease with Multidisciplinary Treatments-A Case Series and Literature Review.Diagnostics (Basel, Switzerland) · 2025Article
- Article
- Calciphylaxis in the Upper GI Tract in an ESRD Patient: An Atypical Presentation and Review of Literature.Case reports in nephrology · 2025Article
- Course and treatment of severe osteoporosis complicated by calciphylaxis: a case report.JBMR plus · 2025Article
- Article
- Article
- Calciphylaxis Episodes in the Australia and New Zealand Dialysis and Transplant Registry.Kidney international reports · 2024Article
- Catheter-directed thrombolysis for critical hand ischemia with failed distal venous arterialization.Cardiovascular intervention and therapeutics · 2024Article
- Scrotal calciphylaxis in a fifty-one-year-old man with end-stage renal disease and prior bacteremia.Urology case reports · 2023Article
- Calciphylaxis in a patient with hypoparathyroidism and MEN-1 syndrome.Endocrinology, diabetes & metabolism case reports · 2023Article
- Calciphylaxis during the course of psoriatic arthritis patient. Is it coincidence? A case report.Annals of medicine and surgery (2012) · 2023Article
- Chronic skin ulcers in hemodialysis patient: A fatal case of calciphylaxis.Radiology case reports · 2023Article
- Refractory wounds induced by normal-renal calciphylaxis: An under-recognised calcific arteriolopathy.International wound journal · 2023Review
- Calciphylaxis, beware the ophthalmic mimic: A case series.Clinical nephrology. Case studies · 2023Article
- Painless Scrotal Ulcers Become Something Unexpected: A Rare Case of Scrotal Calciphylaxis.Cureus · 2022Article
- Retinal artery and vein occlusion in calciphylaxis.American journal of ophthalmology case reports · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
purpose of reviewCalciphylaxis remains a poorly understood vascular calcification disorder with predilection for patients with end-stage renal disease (ESRD). Recent data from large patient registries and databases have begun to provide information regarding incidence, risk factors, and outcomes in patients with calciphylaxis. RECENT
findingsThe most recent estimate places the incidence of calciphylaxis at 3.5 new cases/1000 patient-years among the patients with ESRD on chronic hemodialysis. It is possible that misdiagnosis or subclinical disease may attribute to lower than the true incidence. There is a suggestion that the incidence is higher in peritoneal dialysis patients compared with patients with hemodialysis. Recent studies have identified a number of risk factors and point to the effects of vitamin K deficiency mediated impairment in Matrix Gla Protein carboxylation as one of the likely pathogenic mechanisms. The outcomes in calciphylaxis patients remain poor with mortality approaching 30% at 6 months and 50% at 12 months. SUMMARY: The present review describes recent literature in the field of calciphylaxis. Calciphylaxis registries and specimen biorepositories promise to provide insights into the pathogenesis of calciphylaxis and will pave the way for much needed clinical trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.